Both medications also carry a serious warning about a potential risk of thyroid tumors, including medullary thyroid carcinoma, based on studies in animals
When Should You Take Fiber if Youre on a GLP-1 Medication
Traditional diabetes management focused primarily on blood sugar control, but modern approaches recognize that cardiovascular risk reduction deserves equal or greater priority
In the tirzepatide trial, participants lost an average of 6.9% of their weight after 12 weeks, while retatrutide participants lost 7.2% at the lowest dose after 24 weeks
While nausea typically peaks during weeks 6-8 and then improves substantially, constipation can appear at any point and may persist throughout treatment
What the Current Evidence Says About Combined Use There is no published clinical trial, regulatory guidance, or peer-reviewed evidence supporting the combined use of tesamorelin and retatrutide